ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05217	Basal cell carcinoma	15/180	68/7206	7.17031817988e-11
ko04340	Hedgehog signaling pathway	14/180	58/7206	8.63134284771e-11
ko04360	Axon guidance	21/180	233/7206	2.84835519031e-07
ko05200	Pathways in cancer	32/180	492/7206	4.07033664278e-07
ko05224	Breast cancer	16/180	174/7206	6.2422429612e-06
ko04550	Signaling pathways regulating pluripotency of stem cells	14/180	165/7206	5.94936388258e-05
ko04110	Cell cycle	13/180	145/7206	6.22278155961e-05
ko04390	Hippo signaling pathway	15/180	188/7206	6.58307983756e-05
ko05222	Small cell lung cancer	9/180	89/7206	0.000353066234598
ko04310	Wnt signaling pathway	13/180	181/7206	0.000568908918371
ko04950	Maturity onset diabetes of the young	5/180	29/7206	0.000671093393223
ko04512	ECM-receptor interaction	8/180	79/7206	0.000745272173985
ko05205	Proteoglycans in cancer	16/180	271/7206	0.00116718727242
ko05206	MicroRNAs in cancer	12/180	177/7206	0.0015280389719
ko03410	Base excision repair	5/180	38/7206	0.00236576113495
ko04330	Notch signaling pathway	6/180	62/7206	0.00431006931931
ko05166	HTLV-I infection	15/180	292/7206	0.0067377756564
ko04111	Cell cycle - yeast	7/180	90/7206	0.00705763430615
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	3/180	19/7206	0.0110624797842
ko01522	Endocrine resistance	8/180	124/7206	0.0121936199633
ko04612	Antigen processing and presentation	6/180	77/7206	0.0122379243211
ko04341	Hedgehog signaling pathway - fly	4/180	38/7206	0.0143350663998
ko05220	Chronic myeloid leukemia	6/180	85/7206	0.0191904926369
ko04391	Hippo signaling pathway - fly	6/180	90/7206	0.0246909327019
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3/180	26/7206	0.0261364751953
ko00514	Other types of O-glycan biosynthesis	3/180	30/7206	0.037971012766
ko04151	PI3K-Akt signaling pathway	16/180	390/7206	0.044300246046
ko04022	cGMP-PKG signaling pathway	1/180	216/7206	0.0453010075679